ArticleKidney international reports2024

Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease.

Tarunveer S Ahluwalia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.